Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.75 -0.07 (-0.24%)
Official Closing Price Updated: 4:10 PM EDT, Aug 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,810,940
Open 28.78
Bid (Size) 28.66 (1)
Ask (Size) 28.69 (1)
Prev. Close 28.82
Today's Range 28.64 - 29.08
52wk Range 25.20 - 36.94
Shares Outstanding 5,606,688,356
Dividend Yield 5.70%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
2 Beaten-Down S&P 500 Dividend Stocks to Buy on the Dip and Hold Forever
These underappreciated dividend payers offer yields above 4% at recent prices. 
Via The Motley Fool
Topics Stocks
Exposures US Equities

Performance

YTD
-3.30%
-3.30%
1 Month
-6.41%
-6.41%
3 Month
+1.59%
+1.59%
6 Month
+6.92%
+6.92%
1 Year
-20.60%
-20.60%

More News

Read More
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
Via The Motley Fool
Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare
From Pfizer Inc.
Via Business Wire
Pfizer's Options Frenzy: What You Need to Know
Via Benzinga
Is Pfizer Stock Ready to Bounce Back?
Via The Motley Fool
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
Via Benzinga
Exposures COVID-19
Eli Lilly’s Path to the Next Trillion Market Capitalization
Via MarketBeat
Is Pfizer Stock Still a Buy After an Unexpected Setback?
Via The Motley Fool
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 High-Yielding Stocks
Via The Motley Fool
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
Via Benzinga
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
Via Benzinga
Exposures COVID-19 Product Safety
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
These 3 Stocks Pay You More Than 5% to Own Them
Via MarketBeat
Mr. Darren Walker, Dr. Albert Bourla, and Secretary General Jens Stoltenberg to be awarded Concordia Leadership Award at the 2024 Annual Summit this September
Via Send2Press
Value Investing: Unearthing 3 Hidden Gems in Today's Market
Via MarketBeat
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
2 Cheap Passive Income Stocks to Buy Now
Via The Motley Fool
3 Top Value Stocks to Buy Right Now
Via The Motley Fool
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
Via Investor's Business Daily
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Via Benzinga
Topics ETFs
Exposures COVID-19 Product Safety
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
Via MarketBeat
Exposures COVID-19 Product Safety
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
Via The Motley Fool
3 Dividend Stocks to Double Up On Right Now
Via The Motley Fool
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.